Aclarion Inc. (Nasdaq: ACON, ACONW) has reported that the Texas Back Institute (TBI) will serve as a new site for the CLARITY (C hronic L ow b A ck pain R andomized I ndependent T rial stud Y) clinical trial. TBI is widely recognized for its contributions to spine technology, education and patient care. The…